This is the protocol for a review and there is no abstract. The objectives are as follows: To assess effectiveness and safety of procarbazine, lomustine, and vincristine chemotherapy (PCV) chemotherapy with other intervention groups in people with recurrent high-grade glioma (HGG). To investigate whether predefined subgroups of people benefit more or less from chemotherapy.
|Journal||Cochrane Database of Systematic Reviews|
|State||Published - Jun 25 2015|
Bibliographical noteFunding Information:
We would like to thank and acknowledge the Cochrane Neuro-oncology Group for their support. We would also like to acknowledge funding support from the Society of Neuro-oncology (SNO).
This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service, or the Department of Health.
© 2015 The Cochrane Collaboration.
ASJC Scopus subject areas
- Pharmacology (medical)